Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Melanoma Research|June 27, 2020
Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1 immunotherapyArian Lasocki, Damien Kee
Hematology/Oncology Clinics of North America|June 2, 2014
Targeted therapies for cutaneous melanomaDamien Kee, Grant McArthur
Therapeutic Advances in Medical Oncology|September 4, 2012
Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumorsDamien Kee, John R Zalcberg
Journal for Immunotherapy of Cancer|September 7, 2019
Anti-programmed cell death protein 1 (anti-PD1) immunotherapy induced autoimmune polyendocrine syndrome type II (APS-2): a case report and review of the literatureAshray Gunjur, Oliver Klein, Damien Kee, et al.
The Medical Journal of Australia|July 8, 2014
Ipilimumab in pretreated patients with unresectable or metastatic cutaneous, uveal and mucosal melanomaMarliese Alexander, James D Mellor, Grant McArthur, et al.
PET Clinics|January 17, 2024
Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin MalignanciesSze-Ting Lee, Natalia Kovaleva, Clare Senko, et al.
Melanoma Research|March 12, 2024
What matters most to people with metastatic uveal melanoma? A qualitative study to inform future measurement of health-related quality of lifeCarrie-Anne Ng, Tim Luckett, Brendan Mulhern, et al.
Clinical & Experimental Ophthalmology|September 24, 2025
Systemic Surveillance Guidelines for Uveal Melanoma: A Systematic ReviewFarzana Y Zaman, Aisha Ghaus, Mark Shackleton, et al.
Asia-Pacific Journal of Clinical Oncology|July 29, 2026
Established Prognostic Scores Predict Screen Failure But Not Post-Enrollment Outcomes in Phase 1 Oncology Trials: A Single Centre Retrospective AuditOrtis Estacio, Eve Malsem, Georgia McGuiness, et al.
Oncoimmunology|April 23, 2021
Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538Oliver Klein, Clare Senko, Matteo S Carlino, et al.
Pageof 4